(adopted November 1999, revised July 2005)
Processors and/or manufacturers of cultivated ginseng (Panax spp.) ingredients and products analyze, by an appropriately validated analytical method at an appropriate and relevant limit of detection, for the presence of quintozene and related compounds, including known degradants and impurities of quintozene*, and also for the presence of difenoconazole;
and further, the analyses identified herein is performed by qualified analytical labs using validated analytical methods;
and further, bulk lots of ginseng are accompanied by a certificate that provides actual test results for quintozene and its degradants, and for difenoconazole;
and further, that in lieu of analysis by the processor or manufacturer, the accompanying certificate identified above may be accepted from a supplier provided that the processor or manufacturer establishes the reliability of the supplier’s analysis in conformity with current good manufacturing practice;
provided that, any cultivated ginseng that is produced in a manner that assures that the ginseng is free of quintozene and related compounds and of difenoconazole is exempted from this requirement.
* PCNB, quintozene; PCA, pentachloroaniline; PCTA, pentachlorothioanisol; HCB, hexachlorobenzene; PCB, pentachlorobenzene; alpha-BHC, alpha-benzenehexachloride; beta-BHC, beta-benzenehexachloride; delta-BHC, delta-benzenehexachloride; gamma-BHC, gamma-benzenehexachloride (lindane); TCA, tetrachloroaniline; and TCZ, technazene.
NOTE: Contact AHPA staff for information to assist in identifying an appropriately validated method for the purpose described in this trade requirement.